News

Features Preparing For Your CDMO Selection Process Five questions that must be answered before starting your CDMO search.
Arcus Biosciences announced that quemliclustat, an investigational small-molecule CD73 inhibitor, was granted orphan drug designation by the U.S. Food and Drug Administration to treat pancreatic ...
AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB ...
Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia (denosumab) and Xgeva (denosumab), respectively, are commercially available in the ...
Ofichem Group has agreed to acquire Avivia B.V., a company specialized in formulation development based in Nijmegen, the Netherlands.
The partnership will integrate SPT Labtech’s firefly liquid handling platform with Semarion’s SemaCyte microcarrier technology to develop a flexible, scalable, and automated workflow that simplifies ...
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines, has expanded its capacity for assembly and packaging with the acquisition of Ivers-Lee Group ...
Aphena Pharma Solutions is a full range packaging and manufacturing service provider in the pharmaceutical (OTC, Rx), medical device, and biologics industries. With our continued investment in ...
A leading contract service organization for more than 40 years, SGS provides best-in-class services to help clients deliver high-quality, safe, and effective medicines to patients. Our solutions cover ...